“The Congress is 2025 will be multidisciplinary, with experts and clinical cases”

He XXXVII National Congress of the Sea 2025which will be held in Sitges (Barcelona) from June 4 to 6, will focus on sustainability, the participation of young researchers and International collaboration. According to its presidents, Xavier painted and Ferran Triasthe main themes will include lipid metabolism, diabetes and hypolipemia therapies. There will be Scholarships For children under 35 years and a Plenary session to highlight new investigations. In addition, the presence of International experts Congress will consolidate as a European reference. With a multidisciplinary approach and the elimination of paper in favor of digital formats, the event promises to boost knowledge and innovation in arteriosclerosis.

What are the main novelties that attendees can expect in the XXXVII National Congress of the SE compared to previous editions?

The main novelties of Congress are 2025 focus on sustainability. As far as possible, we will eliminate paper use, and both posters and communications will be published in digital format. In addition, we will have an app that will centralize all the information of the Congress.

Likewise, the headquarters of the Congress and the main lodging building will be located in the same place, facilitating the participation and improving the comfort of the attendees.

News such as the clinical, photography case contest and meetings with experts will convert Congress be 2025 into a multidisciplinary forum. These initiatives will promote the active participation of specialists from various areas, enriching the exchange of knowledge and strengthening collaboration in the approach of arteriosclerosis and their risk factors.

What thematic or topical areas will be the main focus of Congress and what motivated your selection this year?

The thematic areas focus on alterations of lipid metabolism and also diabetes, obesity, liver metabolic disease and arterial hypertension. The main novelties in the therapeutic of the hypolipemit, as well as in the growing participation and prominence of the new generations interested in arteriosclerosis and vascular risk factors. In addition, basic lipidology and vascular biology acquire even greater relevance, being the fundamental basis of our research and its subsequent clinical application.

What degree of international participation expect for this edition and how global collaboration in arteriosclerosis research is being promoted?

We will have the participation of the president of the Portuguese Society of Arteriosclerosis, with whom we have maintained a narrow link for years. In addition, the presence of other international speakers is planned.

Undoubtedly, the outstanding participation of the members of the SEA, with a relevant role in the European Society of Arteriosclerosis, consolidates our Congress as a reference at European level.

This year a plenary session for the best oral communications has been announced. What do you expect to achieve with this initiative and how will these communications be selected?

Providing greater prominence to the new generations, as mentioned above, through their participation in sessions of greater audience and relevance, not only strengthens its training, but also guarantees the future and continuity of our society. The best communications will be selected by the Scientific Committee of Congress.

Research scholarships are a key element in Congress is 2025. What impact they expect to have knowledge about arteriosclerosis?

Research scholarships are a fundamental pillar of Congress is 2025, since they encourage the generation of new knowledge and support the development of young researchers. These scholarships not only promote innovative studies in arteriosclerosis and vascular risk factors, but also ensure generational relief in research, strengthening the future of our society.

We hope that its impact will be reflected in significant advances in the diagnosis, treatment and prevention of arteriosclerosis, consolidating the SEA as a reference in cardiovascular research at European level.

The call includes specific aid for researchers under 35 years. How are they working to promote the participation of the new generation of researchers in arteriosclerosis?

In Congress, 2025, we firmly bet on the new generation of researchers, and the call for specific aid for children under 35 is a sample of this commitment. We seek not only to facilitate access to resources for their projects, but also give them greater visibility within the Congress, assigning spaces in high -impact and audience sessions.

In addition, we promote your active participation through debate forums, forums with consolidated experts and opportunities to present your work in a high scientific level environment. In this way, we ensure the generational relief and continuity of excellence in arteriosclerosis research.

Given the focus in areas such as Nutrition and Primary Care, how are you integrating professionals from different areas in this congress?

Nutrition and its relationship with vascular risk factors and arteriosclerosis has had and will continue to maintain a main prominence in the SEA. It is worth mentioning the Grande Covián Conference, which is held every year at the beginning of Congress, in honor of Professor Grande Covián, an international prestigious scientist who contributed very relevant to the advancement of nutrition science and its relationship with the metabolism of cholesterol and arteriosclerosis.

In Congress, 2025, we are committed to a multidisciplinary approach, recognizing that the approach to arteriosclerosis and its risk factors requires the collaboration of various specialists. The participation of our working groups is fundamental year after year in Congress, we facilitate the active participation of these groups, giving prominence and space for meetings, where experiences and strategies are shared for more effective and comprehensive care. Our goal is to strengthen joint work and ensure that scientific advances reach the daily care of patients.

Finally, looking beyond Congress, what vision do you have for the Spanish Society of Arteriosclerosis in the coming years and how this Congress will help achieve those goals?

The Spanish Society of Arteriosclerosis (be) has led and will continue to lead the research and clinical practice of lipidology, always with a global vision of vascular risk factors. The diagnosis, prognosis and treatment of these factors, as evidenced by the Biennial Publication of the SEA standards, is being constituted as an essential reference for professionals who are dedicated to the prevention of atherotrombotic cardiovascular disease with an integral approach to the patient.

The Annual Congress of the SE is a forum for the dissemination of knowledge, but also an area of ​​exchange of ideas, of establishment of synergies and collaborations between experimental researchers, epidemiologists, clinicians and other professionals dedicated to the study of vascular pathology. In Congress, the meetings of the working groups of the society take place in which the activities, both teachers, as well as research and the tasks for the coming months are defined.

Likewise, consensus documents on key factors, such as lipoprotein (A), a lipoprotein of high atherogenic, inflammatory and thrombogenic potential, on which different members of society have worked for decades, but only until a few years ago has been recognized as a factor of great relevance to vascular diseases.

It is also necessary to highlight the close collaboration between clinicians and researchers in experimental lipidology and vascular biology, a result of which numerous studies have been contributed to the advancement in the management of arteriosclerosis and their risk factors.